Related Experiment Video

Updated: Mar 26, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K

Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells

Rosa Di Liddo1, Deborah Bridi1, Michele Gottardi2

  • 1Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

International Journal of Oncology
|February 6, 2016
PubMed

Insights

Adrenomedullin (ADM) impacts myeloid leukemia cell differentiation. Inhibiting ADM signaling promotes cell maturation, suggesting ADM as a potential therapeutic target for leukemia.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Hematology

Background:

  • Adrenomedullin (ADM) is a peptide hormone regulating blood pressure, cell growth, and innate immunity.
  • Leukemia involves impaired differentiation of myeloid cells.
  • ADM signaling pathways, including RAMPs/CRLR, PI3K/Akt, and ERK/MAPK, are implicated in cellular processes.

Purpose of the Study:

  • To investigate the role of Adrenomedullin (ADM) signaling in myeloid leukemia cell differentiation.
  • To explore the effects of ADM and its inhibitor (ADM22-52) on leukemia cell proliferation and differentiation.
  • To assess the potential of ADM signaling as a therapeutic target in leukemia.

Main Methods:

  • In vitro culture of HL60 promyelocytic leukemia cells.
  • Exogenous administration of ADM and ADM22-52.
  • Analysis of cell differentiation markers (e.g., CD14, CD31, CD38) and signaling pathways (RAMPs/CRLR, PI3K/Akt, ERK/MAPK).

Main Results:

  • ADM promoted proliferation of HL60 cells with minimal CD14 upregulation.
  • ADM inhibition using ADM22-52 stimulated differentiation towards monocytic and granulocytic lineages.
  • ADM excess in bone marrow niche may enhance leukemia cell migration; ADM inhibition may increase cell retention.

Conclusions:

  • ADM and ADM22-52 differentially affect leukemia cell growth via autocrine/paracrine mechanisms.
  • ADM signaling plays a crucial role in regulating myeloid leukemia cell differentiation.
  • ADM and its inhibitors represent potential therapeutic targets for leukemia intervention.

More Related Videos

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

10.2K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K